SCHEMBL6149987

SCHEMBL6149987

CS(=O)(=O)c1cc(C#N)cc(S(C)(=O)=O)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 5/20 0.72
▸ CYP2C19 P33261 5/20 0.72
▸ KCNH2 Q12809 4/20 0.72
▸ CYP3A4 P08684 3/20 0.72
▸ CYP2D6 P10635 3/20 0.72
▸ ABCC3 O15438 1/20 0.72
▸ ESR1 P03372 1/20 0.72
▸ CYP1A2 P05177 1/20 0.72
▸ PGR P06401 1/20 0.72
▸ CHRM2 P08172 1/20 0.72
▸ ABCB1 P08183 1/20 0.72
▸ ADRA2A P08913 1/20 0.72
▸ CHRM1 P11229 1/20 0.72
▸ DRD1 P21728 1/20 0.72
▸ PTGS1 P23219 1/20 0.72
▸ SLC6A2 P23975 1/20 0.72
▸ ADORA1 P30542 1/20 0.72
▸ ABCC1 P33527 1/20 0.72
▸ OPRM1 P35372 1/20 0.72
▸ ABCC2 Q92887 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etravirine SCHEMBL52691 0.84 CYP2C9 (1.00) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
SCHEMBL6031322 0.83 CYP2C9 (0.75) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL28640238 0.83 CYP2C9 (0.98) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL3219153 0.83 CYP2C9 (0.98) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL1085485 0.82 CYP2C9 (0.83) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
SCHEMBL14439966 0.81 CYP2C9 (0.89) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL1085342 0.81 CYP2C9 (0.88) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL1085575 0.80 CYP2C9 (0.77) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL1085387 0.79 CYP2C9 (0.85) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6
Etravirine SCHEMBL3648113 0.76 CYP2C9 (0.74) CYP2C9CYP2C19KCNH2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567134-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE JANSSEN PHARMACEUTICA N.V. (BE) 2005-08-31 — — EP disclosed
WO-2004050058-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE JANSSEN PHARMACEUTICA N.V. (BE) 2004-06-17 — — WO disclosed
Send feedback